• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2与人表皮生长因子受体2(HER-2)在浸润性和原位乳腺导管癌中同时表达。

Cyclooxygenase-2 and human epidermal growth factor receptor type 2 (HER-2) expression simultaneously in invasive and in situ breast ductal carcinoma.

作者信息

Lucarelli Adrienne Pratti, Martins Maria Marta, Montor Wagner, Oliveira Vilmar, Galvão Maria Antonieta Longo, Piato Sebastião

机构信息

Department of Gynecology and Obstetrics, Santa Casa de Misericórdia de São Paulo Hospital, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.

出版信息

Sao Paulo Med J. 2011 Dec;129(6):371-9. doi: 10.1590/s1516-31802011000600002.

DOI:10.1590/s1516-31802011000600002
PMID:22249792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10868924/
Abstract

CONTEXT AND OBJECTIVE

Cyclooxygenase-2 (COX-2) and human epidermal growth factor receptor type 2 (HER-2) are associated with tumorigenesis. Studies have shown that HER-2 can regulate COX-2 expression. The aim of this study was to evaluate the correlation between COX-2 and HER-2 expression in normal breast epithelium and in ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC) present in the same breast.

DESIGN AND SETTING

Cross-sectional study at the Mastology Unit of the Department of Gynecology and Obstetrics, Santa Casa de Misericórdia de São Paulo Hospital.

METHODS

COX-2 and HER-2 were detected using immunohistochemistry on 100 tissue fragments. HER-2 > +2 was subjected to fluorescence in situ hybridization (FISH).

RESULTS

COX-2 expression was detected in 87%, 85% and 75% of IDC, DCIS and normal epithelium, respectively. HER-2 expression was detected in 34% of IDC and 34% of DCIS. COX-2 in DCIS correlated with HER-2 in IDC (P = 0.049) and DCIS (P = 0.049). COX-2 in normal epithelium correlated with HER-2 in IDC (P = 0.046) and DCIS (P = 0.046). COX-2 in IDC was not associated with HER-2 (P = 0.235). Comparison between COX-2 and HER-2 in DCIS showed that there was a statistically significant difference with regard to nuclear grades II and III and presence of comedonecrosis (P < 0.001). In IDC, there was significant expression with nuclear grades II and III and histological grade II (P < 0.001).

CONCLUSIONS

Our findings provide evidence that HER-2 and COX-2 regulate each other.

摘要

背景与目的

环氧化酶-2(COX-2)和人表皮生长因子受体2(HER-2)与肿瘤发生相关。研究表明,HER-2可调节COX-2的表达。本研究旨在评估COX-2与HER-2在同一乳腺的正常乳腺上皮、导管原位癌(DCIS)和浸润性导管癌(IDC)中的表达相关性。

设计与研究地点

在圣保罗慈悲圣母医院妇产科乳腺科进行的横断面研究。

方法

采用免疫组织化学方法检测100个组织切片中的COX-2和HER-2。HER-2> +2的样本进行荧光原位杂交(FISH)检测。

结果

COX-2在IDC、DCIS和正常上皮中的表达率分别为87%、85%和75%。HER-2在IDC和DCIS中的表达率均为34%。DCIS中的COX-2与IDC中的HER-2相关(P = 0.049),也与DCIS中的HER-2相关(P = 0.049)。正常上皮中的COX-2与IDC中的HER-2相关(P = 0.046),也与DCIS中的HER-2相关(P = 0.046)。IDC中的COX-2与HER-2不相关(P = 0.235)。DCIS中COX-2与HER-2的比较显示,在核分级II和III以及粉刺样坏死的存在方面存在统计学显著差异(P < 0.001)。在IDC中,核分级II和III以及组织学分级II时有显著表达(P < 0.001)。

结论

我们的研究结果提供了证据表明HER-2和COX-2相互调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b6/10868924/54ba4b86d105/1806-9460-spmj-129-06-371-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b6/10868924/54ba4b86d105/1806-9460-spmj-129-06-371-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8b6/10868924/54ba4b86d105/1806-9460-spmj-129-06-371-gf01.jpg

相似文献

1
Cyclooxygenase-2 and human epidermal growth factor receptor type 2 (HER-2) expression simultaneously in invasive and in situ breast ductal carcinoma.环氧化酶-2与人表皮生长因子受体2(HER-2)在浸润性和原位乳腺导管癌中同时表达。
Sao Paulo Med J. 2011 Dec;129(6):371-9. doi: 10.1590/s1516-31802011000600002.
2
Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.环氧化酶-2和芳香化酶在浸润性导管癌、原位导管癌及相邻正常上皮中的免疫组化表达相关性
Breast Cancer Res Treat. 2006 Feb;95(3):235-41. doi: 10.1007/s10549-005-9010-1.
3
Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.免疫组化 COX-2 过表达与浸润性乳腺癌中 HER-2/neu 过表达相关:一项初步研究。
Pathol Res Pract. 2011 Mar 15;207(3):182-7. doi: 10.1016/j.prp.2011.01.005. Epub 2011 Mar 2.
4
[Clinical significance of expression of PI3Kp110α in breast cancer].[PI3Kp110α在乳腺癌中的表达的临床意义]
Zhonghua Zhong Liu Za Zhi. 2016 Oct 23;38(10):743-749. doi: 10.3760/cma.j.issn.0253-3766.2016.10.006.
5
[Aromatase expression in invasive and in situ ductal carcinoma present in the same breast].[同一乳腺中浸润性和原位导管癌中的芳香化酶表达]
Rev Assoc Med Bras (1992). 2009 Nov-Dec;55(6):651-5. doi: 10.1590/s0104-42302009000600008.
6
[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].[脂肪酸合酶在乳腺浸润性导管癌中的表达及其与HER2的关系]
Zhonghua Bing Li Xue Za Zhi. 2013 Apr;42(4):257-61. doi: 10.3760/cma.j.issn.0529-5807.2013.04.010.
7
The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue.导管原位癌病变及浸润性乳腺癌中环氧合酶-2的表达状态与正常乳腺组织中环氧合酶-2的表达相关。
Ann Diagn Pathol. 2006 Dec;10(6):327-32. doi: 10.1016/j.anndiagpath.2006.03.002.
8
Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.细胞角蛋白标志物、雌激素受体α(ER-α)、孕激素受体(PR)、人表皮生长因子受体2/neu(HER-2/neu)和表皮生长因子受体(EGFR)在乳腺单纯导管原位癌(DCIS)及合并浸润性导管癌(IDC)的DCIS中的表达。
Ann Clin Lab Sci. 2007 Spring;37(2):127-34.
9
COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.COX - 2、p16和Ki67在伴有广泛导管内成分的导管原位癌、微浸润性和早期浸润性乳腺癌中的表达。
Bratisl Lek Listy. 2014;115(7):445-51. doi: 10.4149/bll_2014_088.
10
Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma.蛋白激酶Cα在正常乳腺、导管原位癌和浸润性导管癌中的表达。
Eur J Cancer. 2004 Oct;40(15):2269-73. doi: 10.1016/j.ejca.2004.06.027.

引用本文的文献

1
Alterations of COX-2, HER-2/neu and E-Cadherin protein expression in the prostatic adenocarcinoma: preliminary findings.前列腺腺癌中COX-2、HER-2/neu和E-钙黏蛋白蛋白表达的改变:初步研究结果。
Am J Transl Res. 2019 Mar 15;11(3):1653-1667. eCollection 2019.
2
Correlated non-nuclear COX2 and low HER2 expression confers a good prognosis in colorectal cancer.相关的非核COX2和低HER2表达赋予结直肠癌良好的预后。
Saudi J Gastroenterol. 2018 Sep-Oct;24(5):301-306. doi: 10.4103/sjg.SJG_46_18.
3
Chronic psychological stress and its impact on the development of aggressive breast cancer.

本文引用的文献

1
t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: possible role of COX2.t10c12 共轭亚油酸抑制SKBr3乳腺癌细胞中的HER2蛋白并增强细胞凋亡:COX2的可能作用
PLoS One. 2009;4(4):e5342. doi: 10.1371/journal.pone.0005342. Epub 2009 Apr 28.
2
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.使用环氧化酶-2抑制剂和视黄酸X受体选择性视黄酸联合化学预防HER2/neu诱导的乳腺癌
Cancer Prev Res (Phila). 2008 Aug;1(3):208-14. doi: 10.1158/1940-6207.CAPR-08-0021.
3
Cancer-related inflammation.
慢性心理压力及其对侵袭性乳腺癌发展的影响。
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):352-6. doi: 10.1590/S1679-45082015AO3344.
4
Expression of COX-2 and HER-2 in colorectal cancer and their correlation.COX-2和HER-2在结直肠癌中的表达及其相关性。
World J Gastroenterol. 2015 May 28;21(20):6206-14. doi: 10.3748/wjg.v21.i20.6206.
癌症相关炎症
Nature. 2008 Jul 24;454(7203):436-44. doi: 10.1038/nature07205.
4
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients.环氧化酶-2可预测他莫昔芬的不良反应:核人表皮生长因子受体2在乳腺癌患者中发挥作用的一种可能机制。
Endocr Relat Cancer. 2008 Sep;15(3):745-53. doi: 10.1677/ERC-08-0009. Epub 2008 May 9.
5
Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer.增强的核因子κB和活化蛋白-1转录活性与抗雌激素耐药性乳腺癌相关。
BMC Cancer. 2007 Apr 3;7:59. doi: 10.1186/1471-2407-7-59.
6
Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.环氧化酶-2和12-脂氧合酶在人乳腺癌中的表达及其与HER-2/neu和激素受体的关系:对预后和治疗的影响
Indian J Cancer. 2006 Oct-Dec;43(4):163-8. doi: 10.4103/0019-509x.29421.
7
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.选择性环氧化酶-2(COX-2)抑制剂降低人类乳腺癌风险
BMC Cancer. 2006 Jan 30;6:27. doi: 10.1186/1471-2407-6-27.
8
Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.环氧化酶-2在乳腺癌发生中的表达及其与浸润性导管癌中HER-2/neu和p53蛋白表达的关系。
Breast. 2006 Jun;15(3):390-8. doi: 10.1016/j.breast.2005.06.011. Epub 2005 Sep 19.
9
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.导管原位癌中COX-2的表达:与血管内皮生长因子、人表皮生长因子受体2、预后分子标志物及临床病理特征的相关性
Histopathology. 2005 May;46(5):561-8. doi: 10.1111/j.1365-2559.2005.02132.x.
10
Feeding the flame: new research adds to role of inflammation in cancer development.火上浇油:新研究进一步揭示炎症在癌症发展中的作用
J Natl Cancer Inst. 2005 Feb 16;97(4):251-3. doi: 10.1093/jnci/97.4.251.